Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430930 · ClinicalTrials.gov registry record · NA
Pragmatic Trial of Messaging to Providers About Treatment of Chronic Kidney Disease
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT07430930 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 1,000 participants.
The verdict
NCT07430930, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
This study is a cluster-randomized clinical trial to evaluate whether a tailored, user-centered, clinical decision support (CDS) tool can positively influence prescriber behavior and increase prescription of guideline-directed medical therapy (GDMT) among patients with Chronic Kidney Disease (CKD) across a single healthcare center.
Interventions
- OTHER Best practice alert and order set for CKD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07430930
The ClinicalTrials.gov registry entry for NCT07430930 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Best practice alert and order set for CKD is the first listed.
NCT07430930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07430930 about?
NCT07430930 is a clinical study titled "Pragmatic Trial of Messaging to Providers About Treatment of Chronic Kidney Disease". This study is a cluster-randomized clinical trial to evaluate whether a tailored, user-centered, clinical decision support (CDS) tool can positively influence prescriber behavior and increase prescription of guideline-directed medical therapy (GDMT) among patients with Chronic Kidney Disease (CKD) a...
What is the current status of trial NCT07430930?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07430930?
The interventions under investigation include: Best practice alert and order set for CKD (OTHER).
Who is sponsoring clinical trial NCT07430930?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.